Search

Showing "11155" results for ""

Kenya: Court case holds up national ARV supply

50mg of ritonavir may be an effective booster for some protease inhibitors

Larger foreskin size increases HIV infection risk

Stopping efavirenz due to CNS side-effects not associated with blood levels of the drug

Catalysing HIV/TB research: a meeting report

Screening tool for HIV in children not being used effectively by health care workers

Women with HIV co-infected with hepatitis B or C have increased risk of bone problems

Rifabutin dose inadequate alongside Kaletra

UK swine flu vaccination programme set to start - people with HIV a priority

Ugandan bill proposes death penalty for sexually active HIV-positive gay men

Discovery of enzyme structure points way to creating less toxic anti-HIV drugs

Etravirine, darunavir/ritonavir and raltegravir very effective in highly treatment-experienced patients

Relapse common in HIV/HCV co-infected patients after treatment for HCV

Study rates Luxembourg as having the best HIV prevention and care in Europe

Ten percent of South African women report anal sex in the past three months

Thai HIV vaccine study: modest effect is real, argue researchers

Warning issued about rare etravirine allergic reactions

Phambili trial of Merck vaccine shows post-infection benefit in women

Receive the latest HIV research and conference news

Showing "11155" results for ""

Kenya: Court case holds up national ARV supply

50mg of ritonavir may be an effective booster for some protease inhibitors

Larger foreskin size increases HIV infection risk

Stopping efavirenz due to CNS side-effects not associated with blood levels of the drug

Catalysing HIV/TB research: a meeting report

Screening tool for HIV in children not being used effectively by health care workers

Women with HIV co-infected with hepatitis B or C have increased risk of bone problems

Rifabutin dose inadequate alongside Kaletra

UK swine flu vaccination programme set to start - people with HIV a priority

Ugandan bill proposes death penalty for sexually active HIV-positive gay men

Discovery of enzyme structure points way to creating less toxic anti-HIV drugs

Etravirine, darunavir/ritonavir and raltegravir very effective in highly treatment-experienced patients

Relapse common in HIV/HCV co-infected patients after treatment for HCV

Study rates Luxembourg as having the best HIV prevention and care in Europe

Ten percent of South African women report anal sex in the past three months

Thai HIV vaccine study: modest effect is real, argue researchers

Warning issued about rare etravirine allergic reactions

Phambili trial of Merck vaccine shows post-infection benefit in women

Receive the latest HIV research and conference news